Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg?

On the other hand, the WHO-5 follows a positive trend, with higher scores representing better QoL.

also in 10,439 other papers

When evaluating scores, the DLQI exhibits a negative trend where lower scores indicate an improvement in QoL.

also in 3,983 other papers